GlassScriptPhysician profile
Natalie Stevens
NPI 1992932586
$10,956.91
in general payments reported to CMS, 2019-2025
30 companies · $636 in 2025
The $636 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $904 · 2020: $592 · 2021: $1,061 · 2022: $1,414 · 2023: $6,225 · 2024: $126 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Food and Beverage: $1,880 · Travel and Lodging: $292 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Food and Beverage | $1,880.46 |
| Travel and Lodging | $292.33 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $5,550.30 | 2023-2025 | Myfembree |
| Abbvie INC. | $1,308.00 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Avion Pharmaceuticals | $543.04 | 2019-2023 | Balcoltra |
| Daiichi Sankyo INC. | $388.60 | 2021-2024 | Injectafer |
| Evofem Biosciences, INC. | $350.19 | 2021-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $339.24 | 2020-2022 | |
| Aspira Women'S Health INC | $289.84 | 2019-2023 | Ova1 |
| Millicent US INC | $248.65 | 2020-2025 | Intrarosa, Femlyv |
| Amag Pharmaceuticals, INC. | $201.22 | 2019-2020 | |
| Astellas Pharma US INC | $192.76 | 2023-2025 | Veozah |
| Myovant Sciences INC. | $172.63 | 2021-2022 | |
| Scynexis, INC. | $158.72 | 2022 | |
| Vertical Pharmaceuticals, LLC | $134.85 | 2019 | |
| Agile Therapeutics, INC. | $134.83 | 2021-2024 | Twirla |
| Coopersurgical, INC. | $130.76 | 2019-2023 | Paragard T 380a |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $116.59 | 2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $110.77 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $92.86 | 2021-2025 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Mayne Pharma Commercial LLC | $88.79 | 2021-2022 | |
| Allergan, INC. | $65.94 | 2019-2020 | |
| Lupin INC. | $54.57 | 2019-2020 | |
| Duchesnay USA Incorporated | $44.29 | 2019 | |
| Organon LLC | $40.29 | 2022-2023 | Nexplanon |
| Pfizer INC. | $38.77 | 2022-2023 | |
| Mylan Pharmaceuticals INC. | $38.23 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $32.86 | 2025 | Contrave |
| Ascend Therapeutics US, LLC | $32.00 | 2019 | |
| Covidien LP | $28.57 | 2019 | |
| Idorsia Pharmaceuticals US INC | $16.19 | 2023 | Quviviq |
| Merck Sharp & Dohme LLC | $12.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.